Aprea Therapeutics, Inc. Liquidation Value
APRE
Other
Cash & Equivalents
$14.60M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $14.60M
Total Obligations: -$2.76M
$11.83M
Per share: $1.44
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $14.60M
AR: $0
Total Obligations: -$2.76M
$11.83M
Per share: $1.44
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $14.60M
AR: $0
Inventory: $0
Total Obligations: -$2.76M
$11.83M
Per share: $1.44
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $11.83M | $1.44 |
| Liquid Liquidation Value | $11.83M | $1.44 |
| Operating Liquidation Value | $11.83M | $1.44 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $14.60M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $2.76M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 8.2M |
Explore all 87 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $14.60M | N/A | N/A | $713,668 | $2.76M | N/A | N/A | N/A |
| 2025-09-30 | $13.72M | N/A | N/A | $641,322 | $2.68M | N/A | N/A | N/A |
| 2025-06-30 | $16.53M | N/A | N/A | $1.20M | $3.17M | N/A | N/A | N/A |
| 2025-03-31 | $19.28M | N/A | N/A | $1.28M | $3.36M | N/A | N/A | N/A |
▼ Community Notes